Re-defining pain through patient-inspired R&D
Pain is a huge burden on society, impacting not only patients but their families, friends and colleagues. There has been limited success in discovering new pain treatments. Many conditions have no standard of care and in cases where they do exist, they have limited efficacy. We want to change this.We want to re-define the field of pain, creating specialised treatments through patient-inspired R&D.
We aim to:
- Better understand the DISEASE state to identify new TARGETs
- Develop treatments with both symptomatic and disease-modifying potential
- Improve our understanding of the link between inflammation and pain
- Target significant unmet needs within niche disease areas
- Broaden our research reach through partnerships and collaborations
- Investigate small molecule approaches.
A different approach
We see pain as a disease, not a symptom
We understand pain is not just a symptom but also an entire condition in itself that requires specialised treatment. We know that pain is different for everyone and the experience and symptoms don’t just depend on the type of condition, but also the individual patient. By understanding how and why pain is generated in a variety of conditions; we are driving development into innovative pain solutions that will have a truly meaningful impact on patient lives.
Patients are central in the journey towards developing effective pain solutions. Through our work with patient organisations and direct interaction with patients, we have been able to create tangible improved outcomes for patients.
Medical expert perspective
Expert knowledge from medical professionals and researchers is the foundation for our research.
Basic science perspective
Through patient and control tissues, we are starting to identify which genes, RNAs, proteins or metabolites are involved in different disease characteristics.